Review industry progress toward translating geroscience into regulatory pathways using functional metrics and pragmatic stepping-stone indications.
Key Takeaways
- Participants prioritized validated clinical outcome assessments over chronological endpoints for regulatory decisions
- Intrinsic Capacity was proposed as a modular framework scored by individual domains
- Investigators cited absence of a validated surrogate endpoint as the single largest barrier